Reparative inflammation in multiple sclerosis |
| Cantuti-Castelvetri L, Gokce O, Simons M | Seminars in Immunology | 2022 | | |
Remyelination in multiple sclerosis: from basic science to clinical translation. |
| Lubetzki C, Zalc B, Williams A, Stadelmann C, Stankoff B | Lancet Neurology | 2020 | | |
Remyelination by surviving oligodendrocytes is inefficient in the inflamed mammalian cortex. | | Mezydlo A, Treiber N, (...), Kerschensteiner M | Neuron | 2023 | | |
Regulatory myeloid cells paralyze T cells through cell–cell transfer of the metabolite methylglyoxal | | Baumann T, Dunkel A, (...), Höchst B | Nature Immunology | 2020 | | |
Regulation of the programmed cell death protein 1/programmed cell death ligand 1axis in relapsing-remitting multiple sclerosis | | Tsaktanis T, Linnerbauer M, (...), Rothhammer V | Brain Communications | 2023 | | |
Proteomics separates adult-type diffuse high-grade gliomas in metabolic subgroups independent of 1p/19q codeletion and across IDH mutational status |
| Bader JM, Deigendesch N, Misch M, Mann M, Koch A, Meissner F | Cell Reports Medicine | 2022 | | |
Proteomics reveals distinct mechanisms regulating the release of cytokines and alarmins during pyroptosis |
| Phulphagar K, Kühn LI, (...), Meissner F | Cell Reports | 2021 | | |
Proteomic and lipidomic profiling of demyelinating lesions identifies fatty acids as modulators in lesion recovery |
| Penkert H, Bertrand A, (...), Simons M | Cell Reports | 2021 | | |
Probing cell identity hierarchies by fate titration and collision during direct reprogramming |
| Hersbach BA, Fischer DS, (...), Stricker SH | Molecular Systems Biology | 2022 | | |
Pro-inflammatory activation following demyelination is required for myelin clearance and oligodendrogenesis. |
| Cunha MI, Su M, (...), Simons M | Journal of Experimental Medicine | 2020 | | |